Alto Neuroscience Corp - ANRO Market Value

Alto Neuroscience, Inc. (ANRO) develops personalized antidepressants using AI analysis of brain biomarkers, which will provide the company with exceptional pricing power due to inelastic demand. High barriers to entry are established by patents and the complexity of certifying diagnostic tools. The market capitalization is 1.18. This price chart complements the data regarding the precise execution of the R&D strategy by the team led by Amit Etkin.

ANRO Alto Neuroscience: Market Value in the range 02/21/2024 - 11/14/2026

Comprehensive metric breakdowns and analytics for Alto Neuroscience Corp (ANRO)

- market price and analyst price targets:

Price Chart Alto Neuroscience|ANRO - Broker Consensus Forecast

- issuer market value details:

Market Value Alto Neuroscience Corp|ANRO - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share Alto Neuroscience|ANRO - Total Stockholders' Equity|Market Value to Book Value Ratio altoneuroscience.com|ANRO - Total Asset Value of Company

- debt and solvency information:

Total Debt to Capital Alto Neuroscience, Inc.|ANRO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Alto Neuroscience, Inc.|ANRO - Company Aggregate Debts|Debt to Book Capitalization Ratio Alto Neuroscience Corp|ANRO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Alto Neuroscience|Quick Ratio altoneuroscience.com

- business earnings and investment ratios data:

ANRO - Net Profit|Future Profit Alto Neuroscience, Inc.|ANRO - Company Value to Net Income|Future Price to Earnings Alto Neuro|ANRO - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alto Neuroscience Corp|ANRO - Operating income before deduction of amortization|Net earnings per share for the last 12 months Alto Neuroscience|ANRO - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth altoneuroscience.com|ANRO - Net earnings per share growth this year|Earnings growth forecast for next year Alto Neuroscience, Inc.

- revenue and sales details:

ANRO - Company Sales Revenue|Company Projected Revenue Alto Neuroscience|ANRO - Price to Sales|Forward P/S Multiple Alto Neuroscience Corp

Fundamental company analysis:ANRO (Alto Neuroscience)

Product sample of Alto Neuroscience Corp

The development of personalized psychiatry and the demand for neuropreparations create a foundation for the growth of Alto Neuroscience, Inc. (ANRO). The company's current market capitalization reflects a real-time assessment by investors of clinical successes and market sentiment. This metric is calculated as the product of the share price and the total number of outstanding securities. The dynamics of this indicator allow for the mathematical determination of the asset's portfolio weight and the elimination of overvalued positions. The asset is categorized as a high-risk speculative security.

Alto Neuroscience Corp - ANRO Market Value

Comprehensive metric breakdowns and analytics for Alto Neuroscience Corp (ANRO)

Key competitors